The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Initial routes focused on amino acid chain portion coupling, utilizing solid-phase synthesis methodologies to build the long amino acid sequence. Subsequent investigation has explored different approaches,